RxDoctor Payments Data

Stewart Miller

Family · Osyka, MSNPI 1619643897

Payments from drug & device makers

$3,428in general payments, 2019–2025

Across 44 payments — averaging $77.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Teleflex LLC$1K
  • Procept Biorobotics Corporation$320
  • Progenics Pharmaceuticals, Inc.$84
  • Astellas Pharma US Inc$76
  • Sumitomo Pharma America, Inc.$70
  • plus $190 from 8 others

What the payments were for

  • Travel & lodging$2,00258%
  • Food & beverage$1,41341%
  • Education$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,428 in reported general payments places this provider in the 85th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$39,580
Medicare patients
268
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron153$81,863
GemtesaVibegron99$59,434
Estradiol91$5,597
Tamsulosin Hcl626$4,274
Oxybutynin Chloride ErOxybutynin Chloride354$3,859
Finasteride503$3,125
Solifenacin Succinate80$2,029
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst82$1,775
Trimethoprim30$1,754
Testosterone Cypionate22$934
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$158
Ciprofloxacin Hcl23$81
Amitriptyline Hcl16$72
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$64
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$76$81,863153 claims
Sumitomo Pharma America, Inc.Gemtesa$70$59,43499 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,007 family providers in Mississippi.

Other family in Osyka

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →